Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Lower Genital Tract Disease|May 8, 2015
Subepithelial angiogenesis in cervical intraepithelial neoplasiaG L Maxwell, A P Sosson, C Oster, et al.
The American Journal of Tropical Medicine and Hygiene|September 1, 1988
Indigenous human cutaneous leishmaniasis caused by Leishmania tropica in KenyaY Mebrahtu, P Lawyer, J Githure, et al.
Oral Surgery, Oral Medicine, and Oral Pathology|July 1, 1984
Characterization of temporomandibular joint sounds. A preliminary investigation with arthrographic correlationC Oster, R W Katzberg, R H Tallents, et al.
Plos Genetics|October 4, 2008
Time-lapse analysis and mathematical characterization elucidate novel mechanisms underlying muscle morphogenesisChelsi J Snow, Michelle Goody, Meghan W Kelly, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 20, 2024
Transcriptomics reveals transient and dynamic muscle fibrosis and atrophy differences following spinal cord injury in ratsHui Jean Kok, Drew B Fletcher, Jacob C Oster, et al.
Neuropathology and Applied Neurobiology|April 26, 2002
Human medulloblastomas lack point mutations and homozygous deletions of the hSNF5/INI1 tumour suppressor geneJ A Kraus, C Oster, N Sörensen, et al.
Journal of Acquired Immune Deficiency Syndromes|November 1, 1993
The prognostic utility of delayed-type hypersensitivity skin testing in the evaluation of HIV-infected patients. Military Medical Consortium for Applied Retroviral ResearchD L Birx, J Brundage, K Larson, et al.
Journal of Virology|March 1, 1995
Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohortN L Michael, T Mo, A Merzouki, et al.
International Journal of Cancer|June 15, 1985
Regional variation in prevalence of antibody against human T-lymphotropic virus types I and III in Kenya, East AfricaR J Biggar, B K Johnson, C Oster, et al.
Radiation Oncology (London, England)|April 21, 2020
Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trialN Guberina, C Pöttgen, S Kebir, et al.
Pageof 4